Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation.
Dubel
L
L
Farges
O
O
Courvalin
J C
JC
Sebagh
M
M
Johanet
C
C
D000974:Antibodies, Antinuclear / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis*; D015415:Biomarkers; D005500:Follow-Up Studies; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000276:immunology / Q000503:physiopathology* / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008562:Membrane Glycoproteins / Q000276:immunology; D008928:Mitochondria / Q000276:immunology; D015166:Monitoring, Immunologic; D028861:Nuclear Pore Complex Proteins; D009687:Nuclear Proteins / Q000276:immunology; D012008:Recurrence
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D015415:Biomarkers; D008562:Membrane Glycoproteins; C063865:NUP210 protein, human; D028861:Nuclear Pore Complex Proteins; D009687:Nuclear Proteins